Bio-Techne Corp (TECH)
77.29
+1.69
(+2.24%)
USD |
NASDAQ |
May 03, 16:00
77.31
+0.02
(+0.03%)
After-Hours: 20:00
Bio-Techne Enterprise Value: 12.39B for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 03, 2024 | 12.39B |
May 02, 2024 | 12.13B |
May 01, 2024 | 11.79B |
April 30, 2024 | 10.18B |
April 29, 2024 | 10.38B |
April 26, 2024 | 10.31B |
April 25, 2024 | 10.09B |
April 24, 2024 | 10.23B |
April 23, 2024 | 10.26B |
April 22, 2024 | 10.12B |
April 19, 2024 | 10.01B |
April 18, 2024 | 10.02B |
April 17, 2024 | 10.10B |
April 16, 2024 | 10.31B |
April 15, 2024 | 10.54B |
April 12, 2024 | 10.73B |
April 11, 2024 | 11.06B |
April 10, 2024 | 11.17B |
April 09, 2024 | 11.44B |
April 08, 2024 | 10.97B |
April 05, 2024 | 10.77B |
April 04, 2024 | 10.78B |
April 03, 2024 | 10.91B |
April 02, 2024 | 11.05B |
April 01, 2024 | 11.15B |
Date | Value |
---|---|
March 31, 2024 | 11.31B |
March 28, 2024 | 11.38B |
March 27, 2024 | 11.22B |
March 26, 2024 | 11.06B |
March 25, 2024 | 11.19B |
March 22, 2024 | 11.55B |
March 21, 2024 | 11.68B |
March 20, 2024 | 11.61B |
March 19, 2024 | 11.43B |
March 18, 2024 | 11.61B |
March 15, 2024 | 11.71B |
March 14, 2024 | 11.51B |
March 13, 2024 | 11.71B |
March 12, 2024 | 11.96B |
March 11, 2024 | 12.12B |
March 08, 2024 | 12.43B |
March 07, 2024 | 12.41B |
March 06, 2024 | 12.05B |
March 05, 2024 | 11.85B |
March 04, 2024 | 12.08B |
March 01, 2024 | 12.00B |
February 29, 2024 | 11.88B |
February 28, 2024 | 12.00B |
February 27, 2024 | 11.82B |
February 26, 2024 | 11.62B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
6.320B
Minimum
Mar 16 2020
21.26B
Maximum
Sep 24 2021
12.47B
Average
12.09B
Median
Enterprise Value Benchmarks
Agilent Technologies Inc | 41.67B |
Bio-Rad Laboratories Inc | 7.573B |
Revvity Inc | 14.61B |
Twist Bioscience Corp | 2.106B |
AIM ImmunoTech Inc | 7.819M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 49.06M |
Revenue (Quarterly) | 303.43M |
Total Expenses (Quarterly) | 236.43M |
EPS Diluted (Quarterly) | 0.31 |
Gross Profit Margin (Quarterly) | 67.43% |
Profit Margin (Quarterly) | 16.17% |
Earnings Yield | 1.63% |
Operating Earnings Yield | 1.99% |
Normalized Earnings Yield | 1.628 |